Thioredoxin is a negative regulator of cardiac hypertrophy

被引：0
|
作者：
Sadoshima, J. [1 ]
机构：
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Newark, NJ 07103 USA
来源：
FREE RADICAL RESEARCH | 2006年 / 40卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [21] Pka Is A Master Regulator Of Pathological Cardiac Hypertrophy
    Zhang, Xiaoying
    Li, Ying
    Tang, Mingxin
    Ai, Xiaojie
    Szeto, Christopher
    Hua, Xiang
    Chen, Xiongwen
    CIRCULATION RESEARCH, 2014, 115
  • [22] MicroRNA-328 as a regulator of cardiac hypertrophy
    Li, Cui
    Li, Xuelian
    Gao, Xu
    Zhang, Ruixue
    Zhang, Ying
    Liang, Haihai
    Xu, Chaoqian
    Du, Weijie
    Zhang, Yong
    Liu, Xue
    Ma, Ning
    Xu, Zhidan
    Wang, Leimin
    Chen, Xu
    Lu, Yanjie
    Ju, Jiaming
    Yang, Baofeng
    Shan, Hongli
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 173 (02) : 268 - 276
  • [23] ICER is a negative feedback regulator of cardiac hypertrophy and positive mediator of cardiac myocyte apoptosis in response to β-adrenergic receptor stimulation
    Tomita, H
    Nazmy, M
    Yehia, G
    Molina, CA
    Sadoshima, J
    CIRCULATION, 2003, 108 (17) : 150 - 150
  • [24] Cardiac-specific expression of a dominant negative splicing regulator in mice causes cardiac hypertrophy, severe cardiac dysfunction, and sudden death
    Ladd, AN
    Hartley, C
    Taffet, G
    Kearney, D
    Cooper, TA
    CIRCULATION, 2004, 110 (17) : 263 - 263
  • [25] The EF-hand protein Calmyrin is a novel negative regulator of cardiac myocyte hypertrophy and cell death
    Heineke, Joerg
    Benard, Matthew
    Xu, Jian
    Molkentin, Jeffery D.
    CIRCULATION, 2006, 114 (18) : 264 - 264
  • [26] Lysosomal-Associated Protein Transmembrane 5 Functions as a Novel Negative Regulator of Pathological Cardiac Hypertrophy
    Gao, Lu
    Guo, Sen
    Long, Rui
    Xiao, Lili
    Yao, Rui
    Zheng, Xiaolin
    Zhang, Yanzhou
    Wang, Xiaofang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [27] Erbin is a negative modulator of cardiac hypertrophy
    Rachmin, Inbal
    Tshori, Sagi
    Smith, Yoav
    Oppenheim, Amit
    Marchetto, Sylvie
    Kay, Gillian
    Foo, Roger S. -Y.
    Dagan, Noa
    Golomb, Eliahu
    Gilon, Dan
    Borg, Jean-Paul
    Razin, Ehud
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (16) : 5902 - 5907
  • [28] NAB1 is a novel regulator of cardiac hypertrophy
    Engelhardt, S
    Buitrago, M
    Lohse, MJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R89 - R89
  • [29] PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility
    Cha, Hyeseon
    Kim, Ji Myoung
    Oh, Jae Gyun
    Jeong, Moon Hee
    Park, Chang Sik
    Park, Jaeho
    Jeong, Hyeon Joo
    Park, Byung Keon
    Lee, Young-Hoon
    Jeong, Dongtak
    Yang, Dong Kwon
    Bernecker, Oliver Y.
    Kim, Do Han
    Hajjar, Roger J.
    Park, Woo Jin
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 45 (06) : 796 - 803
  • [30] LITAF acts as a novel regulator for pathological cardiac hypertrophy
    Xiang, Mei
    Yang, Feiyan
    Zhou, Yi
    Li, Weijuan
    Zou, Yuanlin
    Ye, Ping
    Zhu, Ling
    Wang, Pi-Xiao
    Chen, Manhua
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2021, 156 : 82 - 94
12345